Balchem (NASDAQ:BCPC) was downgraded by research analysts at BidaskClub from a “sell” rating to a “strong sell” rating in a report released on Friday.

Balchem (BCPC) traded down $0.52 during midday trading on Friday, reaching $81.11. The company’s stock had a trading volume of 77,100 shares, compared to its average volume of 96,274. Balchem has a twelve month low of $71.95 and a twelve month high of $89.50. The company has a quick ratio of 1.49, a current ratio of 2.16 and a debt-to-equity ratio of 0.35. The stock has a market capitalization of $2,616.67, a P/E ratio of 40.76 and a beta of 1.09.

Balchem (NASDAQ:BCPC) last released its quarterly earnings results on Tuesday, November 7th. The basic materials company reported $0.63 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.62 by $0.01. The business had revenue of $150.72 million for the quarter. Balchem had a return on equity of 14.68% and a net margin of 11.11%.

A number of institutional investors have recently bought and sold shares of the business. Riverhead Capital Management LLC raised its position in Balchem by 94.9% in the 2nd quarter. Riverhead Capital Management LLC now owns 1,364 shares of the basic materials company’s stock worth $106,000 after purchasing an additional 664 shares during the period. Victory Capital Management Inc. raised its stake in Balchem by 17.6% during the second quarter. Victory Capital Management Inc. now owns 2,130 shares of the basic materials company’s stock worth $166,000 after purchasing an additional 319 shares during the period. Ladenburg Thalmann Financial Services Inc. raised its stake in Balchem by 158.3% during the third quarter. Ladenburg Thalmann Financial Services Inc. now owns 2,206 shares of the basic materials company’s stock worth $179,000 after purchasing an additional 1,352 shares during the period. Sei Investments Co. raised its stake in Balchem by 117.9% during the second quarter. Sei Investments Co. now owns 2,465 shares of the basic materials company’s stock worth $191,000 after purchasing an additional 1,334 shares during the period. Finally, Zions Bancorporation purchased a new position in Balchem during the third quarter worth about $196,000. 87.24% of the stock is currently owned by institutional investors and hedge funds.

ILLEGAL ACTIVITY NOTICE: This piece of content was originally published by American Banking News and is owned by of American Banking News. If you are viewing this piece of content on another publication, it was copied illegally and republished in violation of United States & international copyright & trademark legislation. The legal version of this piece of content can be viewed at https://www.americanbankingnews.com/2017/12/22/balchem-bcpc-stock-rating-lowered-by-bidaskclub-2.html.

Balchem Company Profile

Balchem Corporation is engaged in the development, manufacture and marketing of specialty performance ingredients and products for the food, nutritional, feed, pharmaceutical, medical sterilization and industrial markets. The Company operates in four segments: Human Nutrition & Health, Animal Nutrition & Health, Specialty Products and Industrial Products.

Receive News & Ratings for Balchem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Balchem and related companies with MarketBeat.com's FREE daily email newsletter.